Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Barchart
Barchart
Jim Van Meerten

Could Diebold Nixdorf Stock Be Your Cash Cow?

  • Diebold Nixdorf (DBD) hit a new 52-week high on July 10.            
  • The stock shows strong technical momentum and has a 100% “Buy” signal via Barchart.
  • Shares are up more than 50% in the past year.
  • Analyst sentiment is bullish, and Diebold’s fundamentals are improving. 

Today’s Featured Stock:

Valued at $2.22 billion, Diebold Nixdorf (DBD) helps transform how people bank and shop. It offers cash recyclers and dispensers, intelligent deposit terminals, teller automation tools and kiosk technologies, as well as physical security solutions and front-end applications for consumer connection points.

What I’m Watching:

I found today’s Chart of the Day by using Barchart’s powerful screening functions. I sorted for stocks with the highest technical buy signals, superior current momentum in both strength and direction, and a Trend Seeker “buy” signal. I then used Barchart’s Flipcharts feature to review the charts for consistent price appreciation. DBD checks those boxes. Since the Trend Seeker signaled a buy on May 1, the stock has gained 32.71%.

 

DBD Price vs. Daily Moving Averages:

www.barchart.com

Barchart Technical Indicators for Diebold Nixdorf:

Editor’s Note: The technical indicators below are updated live during the session every 20 minutes and can therefore change each day as the market fluctuates. The indicator numbers shown below therefore may not match what you see live on the Barchart.com website when you read this report. These technical indicators form the Barchart Opinion on a particular stock.

Diebold Nixdorf shares hit a new 52-week high on July 10, touching $60.33 in intraday trading. As of this writing, shares had retreated slightly and were trading 0.2% below the new high.

  • DBD has an 100% technical “Buy” signal.
  • The stock recently traded at $59.87, above its 50-day moving average of $50.93.
  • Diebold Nixdorf has a Weighted Alpha of +59.07.
  • The stock has gained 52.74% over the past year.
  • DBD has its Trend Seeker “Buy” signal intact.
  • Diebold Nixdorf is trading above its 20, 50 and 100-day moving averages.
  • The stock made 15 new highs and gained 18.04% in the last month.
  • Relative Strength Index is at 87.48%.
  • The technical support level is $59.40.

Don’t Forget the Fundamentals:

  • $2.22 billion market cap.
  • Trailing price-earnings ratio of 21.79x.
  • Revenue is projected to grow 1% this year and another 1.96% next year.
  • Earnings are estimated to increase 46.92% this year and increase an additional 35.44% next year.

Analyst and Investor Sentiment on Diebold Nixdorf:

I don’t buy stocks because everyone else is buying, but I do realize that if major firms and investors are dumping a stock, it’s hard to make money swimming against the tide.

It looks like Wall Street analysts are bullish, along with some major advisory sites.

  • The Wall Street analysts tracked by Barchart issued three “Strong Buy” opinions on the stock.
  • Value Line gives the stock its highest rating.
  • CFRA’s MarketScope rates the stock a “Buy.”
  • Morningstar thinks the stock is 8% undervalued.
  • 8,540 investors monitor the stock on Seeking Alpha, which rates the stock a “Hold.”

The Bottom Line:

Diebold Nixdorf currently has momentum and is hitting new highs.

I caution that DBD is volatile and speculative — use strict risk management and stop-loss strategies.

Today’s Chart of the Day was written by Jim Van Meerten. Read previous editions of the daily newsletter here.

Additional disclosure: The Barchart of the Day highlights stocks that are experiencing exceptional current price appreciation. They are not intended to beA buy recommendations as these stocks are extremely volatile and speculative. Should you decide to add one of these stocks to your investment portfolio it is highly suggested you follow a predetermined diversification and moving stop loss discipline that is consistent with your personal investment risk tolerance.

On the date of publication, Jim Van Meerten did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here.
Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.